Legend Capital Portfolio Company Giant Biogene Successfully Lists on the HKEX
HONG KONG, Nov 7, 2022 – (ACN Newswire via SEAPRWire.com) – On November 4, 2022, Legend Capital portfolio company Giant Biogene (2367.HK) was successfully listed on the main board of […]